Selio Medical is a leading brand in medical device innovation, offering groundbreaking solutions to reduce the risk of pneumothorax during transthoracic needle biopsy procedures. Pneumothorax, or a collapsed lung, is a dangerous complication that affects approximately 1 in 3 patients undergoing a lung biopsy. Selio Medical's unique approach involves providing pneumothorax protection before the biopsy even takes place.

Their Selio Sealant System is a single-use, prophylactic device that integrates seamlessly with the current standard of care. The Selio Sealant System includes a percutaneous delivery needle and a novel biodegradable hydrogel sealant. By pre-sealing the access route into the lung, Selio Medical ensures pneumothorax protection for the in-patient, allowing them to safely return home on the same day as their procedure.

This not only improves the quality of care for patients but also prevents further treatment and costs. Selio Medical has received recognition and support for their innovative technology, including a recent €2. 5 million funding from the European Innovation Council Accelerator program.

They continue to develop their platform technology to benefit lung cancer patients worldwide. If you're interested in joining their team, Selio Medical offers exciting career opportunities in engineering and operations management. Contact them today to learn more about their groundbreaking solutions and career opportunities